Xlife Sciences AG (XLS) - Total Liabilities

Latest as of June 2025: CHF232.84 Million CHF ≈ $294.37 Million USD

Based on the latest financial reports, Xlife Sciences AG (XLS) has total liabilities worth CHF232.84 Million CHF (≈ $294.37 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore XLS cash flow conversion to assess how effectively this company generates cash.

Xlife Sciences AG - Total Liabilities Trend (2019–2024)

This chart illustrates how Xlife Sciences AG's total liabilities have evolved over time, based on quarterly financial data. Check how resilient are Xlife Sciences AG's assets to evaluate the company's liquid asset resilience ratio.

Xlife Sciences AG Competitors by Total Liabilities

The table below lists competitors of Xlife Sciences AG ranked by their total liabilities.

Company	Country	Total Liabilities
Cornish Metals Inc. V:CUSN	Canada	CA$15.90 Million
San Lien Technology TWO:5493	Taiwan	NT$2.82 Billion
KULR Technology Group Inc NYSE MKT:KULR	USA	$8.11 Million
IL Science Co. Ltd KQ:307180	Korea	₩125.87 Billion
Ace Technologies Corp KQ:088800	Korea	₩192.80 Billion
Adriano Care SOCIMI SAU MC:YADR	Spain	€132.09 Million
Marvipol S.A. WAR:MVP	Poland	zł714.67 Million
Samyang Packaging KO:272550	Korea	₩263.20 Billion

Liability Composition Analysis (2019–2024)

This chart breaks down Xlife Sciences AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Xlife Sciences AG market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.08	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	0.00	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.77	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.43	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Xlife Sciences AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Xlife Sciences AG (2019–2024)

The table below shows the annual total liabilities of Xlife Sciences AG from 2019 to 2024.

Year	Total Liabilities	Change
2024-12-31	CHF235.11 Million ≈ $297.25 Million	-3.57%
2023-12-31	CHF243.82 Million ≈ $308.25 Million	-4.38%
2022-12-31	CHF255.00 Million ≈ $322.38 Million	-5.15%
2021-12-31	CHF268.83 Million ≈ $339.87 Million	+384.27%
2020-12-31	CHF55.51 Million ≈ $70.18 Million	-2.00%
2019-12-31	CHF56.64 Million ≈ $71.61 Million	--

About Xlife Sciences AG

SW:XLS Switzerland Biotechnology

Market Cap

$150.94 Million

CHF119.39 Million CHF

Market Cap Rank

#18425 Global

#184 in Switzerland

Share Price

CHF20.70

Change (1 day)

-2.36%

52-Week Range

CHF16.55 - CHF26.00

All Time High

CHF52.00